These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1995881)
61. Thermodynamic analysis of the reaction of phosphoramide mustard with protector thiols. Seitz DE; Katterjohn CJ; Rinzel SM; Pearce HL Cancer Res; 1989 Jul; 49(13):3525-8. PubMed ID: 2499418 [TBL] [Abstract][Full Text] [Related]
62. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide. Plowchalk DR; Mattison DR Toxicol Appl Pharmacol; 1991 Mar; 107(3):472-81. PubMed ID: 2000634 [TBL] [Abstract][Full Text] [Related]
63. Design, synthesis, and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach. Wang RB; Zhou W; Meng QQ; Zhang X; Ding J; Xu Y; Song HL; Yang K; Cui JH; Li SS ChemMedChem; 2014 Dec; 9(12):2798-808. PubMed ID: 25234005 [TBL] [Abstract][Full Text] [Related]
64. Analysis of phosphoramide mustard by reversed-phase ion pair high pressure liquid chromatography. Hardy RW; Moore MJ; Erlichman C; Soldin SJ Ther Drug Monit; 1987 Jun; 9(2):221-6. PubMed ID: 3617163 [TBL] [Abstract][Full Text] [Related]
65. Synthesis and evaluation of 1,2,2-tris(sulfonyl)hydrazines as antineoplastic and trypanocidal agents. Shyam K; Penketh PG; Divo AA; Loomis RH; Patton CL; Sartorelli AC J Med Chem; 1990 Aug; 33(8):2259-64. PubMed ID: 2374151 [TBL] [Abstract][Full Text] [Related]
66. Alkylation of guanosine and deoxyguanosine by phosphoramide mustard. Mehta JR; Przybylski M; Ludlum DB Cancer Res; 1980 Nov; 40(11):4183-6. PubMed ID: 7471059 [TBL] [Abstract][Full Text] [Related]
67. Influence of mustard group structure on pathways of in vitro metabolism of anticancer N-(2-hydroxyethyl)-3,5-dinitrobenzamide 2-mustard prodrugs. Helsby NA; Goldthorpe MA; Tang MH; Atwell GJ; Smith EM; Wilson WR; Tingle MD Drug Metab Dispos; 2008 Feb; 36(2):353-60. PubMed ID: 17998296 [TBL] [Abstract][Full Text] [Related]
68. Synthesis and biological evaluation of hypoxia-activated prodrugs of SN-38. Jin C; Zhang Q; Lu W Eur J Med Chem; 2017 May; 132():135-141. PubMed ID: 28350997 [TBL] [Abstract][Full Text] [Related]
69. Cytotoxic evaluation of some N-acyl and N-acyloxy analogues of 3,5-bis(arylidene)-4-piperidones. Dimmock JR; Arora VK; Chen M; Allen TM; Kao GY Drug Des Discov; 1994 Jul; 12(1):19-28. PubMed ID: 7578805 [TBL] [Abstract][Full Text] [Related]
70. Vomiting induced by cyclophosphamide and phosphoramide mustard in cats. Fetting JH; McCarthy LE; Borison HL; Colvin M Cancer Treat Rep; 1982 Aug; 66(8):1625-9. PubMed ID: 7105052 [TBL] [Abstract][Full Text] [Related]
71. Design, Synthesis, and Biological Evaluation of Artemisinin-Piperazine-Phosphoramide Mustard Hybrids as Potential Anticancer Agents. Wei MX; Zhang SS; Sun X; Ji Y; Yang PW; Li XQ ChemMedChem; 2022 Sep; 17(17):e202200239. PubMed ID: 35771689 [TBL] [Abstract][Full Text] [Related]
72. Some antitumor agents derived from benzaldehyde nitrogen mustards. Florvall L Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623 [No Abstract] [Full Text] [Related]
74. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Dirven HA; van Ommen B; van Bladeren PJ Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469 [TBL] [Abstract][Full Text] [Related]
75. 31P NMR studies of the kinetics of bisalkylation by isophosphoramide mustard: comparisons with phosphoramide mustard. Boal JH; Williamson M; Boyd VL; Ludeman SM; Egan W J Med Chem; 1989 Aug; 32(8):1768-73. PubMed ID: 2754703 [TBL] [Abstract][Full Text] [Related]